Literature DB >> 10369829

Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases.

K P Bhatia1, A Münchau, P D Thompson, M Houser, V S Chauhan, M Hutchinson, A H Shapira, C D Marsden.   

Abstract

Three patients are reported on who developed transient generalised weakness after receiving therapeutic doses of botulinum toxin for cervical dystonia (one case) and symptomatic hemidystonia (two cases) respectively. Clinical and electrophysiological findings were in keeping with mild botulism. All patients had received previous botulinum toxin injections without side effects and one patient continued injections without recurrence of generalised weakness. The cause is most likely presynaptic inhibition due to systemic spread of the toxin. Patients with symptomatic dystonia may be more likely to have this side effect and botulinum toxin injections in these patients should be carried out cautiously.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369829      PMCID: PMC1736426          DOI: 10.1136/jnnp.67.1.90

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

Review 1.  Uses of botulinum toxin injection in medicine today.

Authors:  A Münchau; K P Bhatia
Journal:  BMJ       Date:  2000-01-15

2.  Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.

Authors:  Andrea L Nicol; Irene I Wu; F Michael Ferrante
Journal:  Anesth Analg       Date:  2014-06       Impact factor: 5.108

3.  Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database.

Authors:  Salma Ahsanuddin; Savannah Roy; Wissam Nasser; Roman Povolotskiy; Boris Paskhover
Journal:  Aesthetic Plast Surg       Date:  2020-10-30       Impact factor: 2.326

Review 4.  Progress in the understanding and treatment of chronic anal fissure.

Authors:  K McCallion; K R Gardiner
Journal:  Postgrad Med J       Date:  2001-12       Impact factor: 2.401

Review 5.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 6.  Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.

Authors:  Beth E Crowner; Diego Torres-Russotto; Alexandre R Carter; Brad A Racette
Journal:  Clin Neuropharmacol       Date:  2010 Sep-Oct       Impact factor: 1.592

7.  Botulinum toxin.

Authors:  P K Nigam; Anjana Nigam
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

8.  Botulinum Toxin Deaths: What is the Fact?

Authors: 
Journal:  J Cutan Aesthet Surg       Date:  2008-07

Review 9.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.

Authors:  Allison W Willis; Beth Crowner; Janice E Brunstrom; Abigail Kissel; Brad A Racette
Journal:  Dev Med Child Neurol       Date:  2007-11       Impact factor: 5.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.